Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David ADAMS
Bicetre Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Bicetre
Le Kremlin-Bicêtre, Kremlin Bicetre, France
- Chu Martinique
Martigues, Martinique, France
- Chu Saint Etienne
Saint-Etienne, Saint Etienne, France
- Chu Grenoble
Grenoble, France
- Chru Lille
Lille, France
- Chu Dupuytren
Limoges, France
- Chu la Timone
Marseille, France
- Hopital Guy-de-Chauliac
Montpellier, France
- Hôpital de la Salpetrière
Paris, France
- Hopital de Hautepierre
Strasbourg, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Mar 2017
- Primary completion
- 30 Sept 2021
- Completion
- 10 Dec 2021
- Last update posted
- 8 Dec 2022
- Registered enrollment
- 560
- Registry id
- NCT03373370
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.